Stock data

醫揚 (6569)

醫揚 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$121.84M, down 2.1% from a year earlier. EPS over the last four quarters totals NT$4.71.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 醫揚 in Insightr